A Modular Design of a Cholera Toxin B Subunit‐Scaffolded Sub‐Virion Nanoparticle Vaccine Against West Nile Virus
Microbial Biotechnology · 2026-06 · 19 (6)
DOI: 10.1111/1751-7915.70391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Biotechnology, online erschienen am 03.06.2026. Verfasst von Hyun Byun und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated OMICS for Biomedical Science, Yonsei University, Seoul, South Korea. Hauptthemen laut MEDLINE: Cholera Toxin, West Nile virus, West Nile Virus Vaccines, West Nile Fever. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Health and Welfare.
Abstract (Originalsprache)
Although veterinary vaccines against West Nile virus (WNV) have been developed, no approved human vaccine is currently available, highlighting the need for scalable and safer WNV vaccine candidates. In this study, a recombinant WNV subunit nanoparticle vaccine was developed by displaying the envelope protein domain III (ED3) on a cholera toxin B subunit (CTB) pentameric scaffold. The resulting recombinant protein comprising CTB‐ED3 was expressed predominantly as soluble nanoparticles in Escherichia coli . Immunized mice produced strong humoral responses with balanced IgG1/IgG2a ratios, and some constructs achieved neutralizing titres comparable to those elicited by formalin‐inactivated WNV. Importantly, no cross‐reactivity with other flaviviruses was observed, alleviating potential concerns about ADE. These findings demonstrate that CTB‐ED3 is assembled into multimeric nanoparticles in bacteria, offering a cost‐effective, scalable, and biosafe platform for developing subunit nanoparticle vaccines against WNV and potentially other flaviviruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrated OMICS for Biomedical Science, Yonsei University, Seoul, South Korea.
- The Interdisciplinary Graduate Program in Integrative Biotechnology, Yonsei University, Incheon, South Korea.
- Department of Biotechnology, Yonsei University, Seoul, South Korea.
- Division of Acute Viral Diseases, Center for Emerging Virus Research, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, South Korea.
- Graduate Program in Biomaterials Science and Engineering, Yonsei University, Seoul, South Korea.
- Vaxdigm Co., Ltd., Seoul, South Korea.
ORCID-Profile: Tae Hoon Kim, Baik Lin Seong
Förderung
- Ministry of Health and Welfare
Zitieren
APA
Byun, H., Kim, T. H., Sung, J., Lee, J. M., Shim, S. M., Kang, S. H., Kang, H., Moon, D. H., Park, S. H., Kim, D., Kim, S. J., Kim, S., Han, G., & Seong, B. L. (2026). A Modular Design of a Cholera Toxin B Subunit‐Scaffolded Sub‐Virion Nanoparticle Vaccine Against West Nile Virus. Microbial Biotechnology, 19(6). https://doi.org/10.1111/1751-7915.70391
Vancouver
Byun H, Kim TH, Sung J, Lee JM, Shim SM, Kang SH, et al. A Modular Design of a Cholera Toxin B Subunit‐Scaffolded Sub‐Virion Nanoparticle Vaccine Against West Nile Virus. Microbial Biotechnology. 2026;19(6). doi:10.1111/1751-7915.70391
BibTeX
@article{Byun2026,
author = {Byun, Hyun and Kim, Tae Hoon and Sung, Jemin and Lee, Jung-Min and Shim, Sang-Mu and Kang, Sin Hae and Kang, Hanul and Moon, Dah Hyun and Park, Seong Hyun and Kim, Doda and Kim, Sung Jae and Kim, Seunghoo and Han, Gyoonhee and Seong, Baik Lin},
title = {A Modular Design of a Cholera Toxin B Subunit‐Scaffolded Sub‐Virion Nanoparticle Vaccine Against West Nile Virus},
journal = {Microbial Biotechnology},
year = {2026},
volume = {19},
number = {6},
doi = {10.1111/1751-7915.70391}
}
EUVIMED